Osteoarthritis News and Research

Latest Osteoarthritis News and Research

Pfizer provides information about its COX-2 product Bextra (valdecoxib)

In view of the increased focus on alternative treatment options for people with arthritis, Pfizer is providing information to healthcare professionals about its COX-2 product Bextra® (valdecoxib).

18 Oct 2004

Topical nonsteroidal anti-inflammatory drug eases symptoms of osteoarthritis of the knee

Symptoms of primary osteoarthritis of the knee, including pain and stiffness, were significantly improved in patients who used a topical nonsteroidal anti-inflammatory drug (NSAID), according to an article in the October 11 issue of The Archives of Internal Medicine.

11 Oct 2004

Study underscores the need for improved prevention and treatment of torn knee ligaments among young female athletes

Of the more than 17 million players participating in organized soccer nationwide, 7 million are female. While offering an equal opportunity playing field for student athletes, soccer has one unfortunate gender bias: women are more susceptible to knee injury.

7 Oct 2004

Natural alternatives to osteoarthritis drug

The recall of Vioxx should come as a major sign of the need to look for safer alternatives for osteoarthritis treatment, according to the Director of the Australian Centre for complementary Medicine Education and Research (ACCMER), Professor Stephen Myers.

5 Oct 2004

Immediate voluntary world-wide withdrawal of Vioxx (rofecoxib)

Pharmaceutical company, Merck Sharp & Dohme has announced an immediate voluntary world-wide withdrawal of the drug, Vioxx (rofecoxib), commonly used for patients with rheumatoid or osteoarthritis.

4 Oct 2004

MHRA advice following withdrawal of Vioxx (rofecoxib)

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued advice following the withdrawal of a widely-used pain-killer and anti-inflammatory drug Vioxx (rofecoxib).

4 Oct 2004

Data demonstrate that Celebrex does not increase the risk of heart attack or stroke in patients with arthritis and pain

Pfizer has said that three large long-term Celebrex (celecoxib capsules) studies involving more than 6,000 patients have not shown any significant safety issues and are expected to continue to completion.

4 Oct 2004

Spinal cord injury specialist says 60 percent of his patients are obese

As Americans face a growing epidemic of obesity, people with spinal cord injuries find themselves particularly vulnerable to the serious complications that come with carrying around extra pounds.

10 Sep 2004

Magnetic resonance imaging helps measure osteoarthritis

Researchers from Australia's Monash University have revolutionised knee scans with the development of new technology that harnesses the power of magnetic resonance imaging (MRI).

10 Sep 2004

Ageing population and technological progress combine to drive European orthopaedic braces and supports market

By 2020, the elderly are expected to comprise almost a quarter of Europe's total population. This changing demography is set to underpin a rise in the incidence of age-related orthopaedic problems

31 Aug 2004

COX2 inhibitor lumiracoxib could be an effective treatment for osteoarthritis

The use of non-selective non-steroidal anti-inflammatory drugs (NSAIDs) is widespread to reduce the pain associated with osteoarthritis; however the sideeffects of these drugs can be severe, sometimes leading to gastro-intestinal ulcer complications which account for around 7000 US and 1000 UK deaths each year.

21 Aug 2004

Osteoarthritis twice as likely if parents suffer the condition

New research published in the Annals of the Rheumatic Diseases, shows that children whose parents have osteoarthritis of the knee are twice as likely to develop the condition themselves. This research suggests that genetic make-up plays a role in osteoarthritis development.

12 Aug 2004

New knee-scanning procedures will provide more accurate diagnosis methods for doctors

New knee-scanning procedures developed by Australia's Monash University will provide more accurate diagnosis methods for doctors and save patients time and money.

10 Aug 2004

Clinical trial of lipase inhibitor for the treatment of obesity

Peptimmune, Inc. a privately held biotechnology company, announced that physicians have treated the first participant in a clinical trial to evaluate the safety, tolerability and pharmacokinetics of GT389-255, a lipase inhibitor conjugated to a fat binding polymer for the treatment of obesity.

9 Aug 2004

A new marker for osteoarthritis

Osteoarthritis (OA) is a common, crippling age-related disease characterized by the gradual destruction of cartilage cushioning the joints.

5 Aug 2004

Researchers study whether people’s genetic makeup could make them more likely to develop osteoarthritis of the knee and hip

Researchers at The University of Nottingham are studying whether people’s genetic makeup could make them more likely to develop osteoarthritis of the knee and hip — the most common medical condition to affect the joints.

3 Aug 2004

Joint inflammation

Members of the baby boomer generation are beginning to reach their 50s and 60s and seniors are living longer than ever, causing a large influx of older men and women in our society.

2 Aug 2004

Using topical non-steroidal anti-inflammatory drugs to relieve the pain of osteoarthritis is only beneficial for the first two weeks

Using topical non-steroidal anti-inflammatory drugs (NSAIDS) to relieve the pain of osteoarthritis is only beneficial for the first two weeks, finds a study available on bmj.com today.

29 Jul 2004

Women twice as likely as men to develop some musculoskeletal disorders

Musculoskeletal pain is an extremely common problem. In this age of fitness promotion, many people develop musculoskeletal disorders related to overuse of weak or improperly stretched muscles, tendons or ligaments. Strenuous daily vocational activities, such as lifting, bending, or prolonged typing, can cause musculoskeletal pain through constant stress on the musculoskeletal system.

22 Jul 2004

Study to establish the effectiveness of Devil’s Claw as a treatment for osteoarthritis of the knee joint

The University of Southampton’s Complementary Medicine Research Unit is looking for volunteers to take part in a new study which aims to establish the effectiveness of a well-known herbal remedy as a treatment for osteoarthritis of the knee joint.

19 Jul 2004

Osteoarthritis News and Research

Latest Osteoarthritis News and Research

Pfizer provides information about its COX-2 product Bextra (valdecoxib)

Topical nonsteroidal anti-inflammatory drug eases symptoms of osteoarthritis of the knee

Study underscores the need for improved prevention and treatment of torn knee ligaments among young female athletes

Natural alternatives to osteoarthritis drug

Immediate voluntary world-wide withdrawal of Vioxx (rofecoxib)

MHRA advice following withdrawal of Vioxx (rofecoxib)

Data demonstrate that Celebrex does not increase the risk of heart attack or stroke in patients with arthritis and pain

Spinal cord injury specialist says 60 percent of his patients are obese

Magnetic resonance imaging helps measure osteoarthritis

Ageing population and technological progress combine to drive European orthopaedic braces and supports market

COX2 inhibitor lumiracoxib could be an effective treatment for osteoarthritis

Osteoarthritis twice as likely if parents suffer the condition

New knee-scanning procedures will provide more accurate diagnosis methods for doctors

Clinical trial of lipase inhibitor for the treatment of obesity

A new marker for osteoarthritis

Researchers study whether people’s genetic makeup could make them more likely to develop osteoarthritis of the knee and hip

Joint inflammation

Using topical non-steroidal anti-inflammatory drugs to relieve the pain of osteoarthritis is only beneficial for the first two weeks

Women twice as likely as men to develop some musculoskeletal disorders

Study to establish the effectiveness of Devil’s Claw as a treatment for osteoarthritis of the knee joint

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Osteoarthritis News and Research

Latest Osteoarthritis News and Research

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in